Results 141 to 150 of about 6,703 (220)

Design and synthesis of thiadiazoles as anticancer, apoptotic, and VEGFR-2 inhibitors. [PDF]

Future Med Chem
Elgammal WE, Elkady H, Dahab MA, Mahdy HA, Hagras M, Nofal A, Alsfouk BA, Elkaeed EB, Eissa IH, Metwaly AM.   +9 more
europepmc   +1 more source

Antimicrobial Activity of 1,3,4-Thiadiazole Derivatives. [PDF]

Pharmaceuticals (Basel)
Górecki S, Kudelko A, Olesiejuk M.
europepmc   +1 more source

Synthesis of Novel Thiazole/Thiadiazole Conjugates of Fluoroquinolones as Potent Antibacterial and Antimycobacterial Agents. [PDF]

Chem Biol Drug Des
Poyraz Yılmaz P, Kulabaş N, Bozdeveci A, Vagolu SK, Imran M, Tatar E, Alpay Karaoğlu Ş, Sriram D, Mahmood AAR, Küçükgüzel İ.   +9 more
europepmc   +1 more source

Hydrazides as Powerful Tools in Medicinal Chemistry: Synthesis, Reactivity, and Biological Applications. [PDF]

Molecules
Teixeira S, Castanheira EMS, Carvalho MA.   +2 more
europepmc   +1 more source

ML216 Alleviates Age-Related Cardiac Fibrosis by Suppressing TGF-β1 Signaling Pathway. [PDF]

Int J Mol Sci
Liu W, Cui F, Huang X, Liang N, Li J.
europepmc   +1 more source

Targeting Glutaminase Isoforms GLS and GLS2 in Luminal Breast Cancer. [PDF]

Int J Mol Sci
Masisi BK, El Ansari R, Fakroun A, Erkan B, Rakha EA, Green AR.   +5 more
europepmc   +1 more source

Machine learning prediction of multiple distinct high-affinity chemotypes for α-synuclein fibrils. [PDF]

Chem Commun (Camb)
Li X, Perez RM, Tu Z, Mach RH, Giannakoulias S, Petersson EJ.   +5 more
europepmc   +1 more source

Design, synthesis and biological evaluation of non-glucosidal based 1,3,4-thiadiazoles as SGLT-2 inhibitors. [PDF]

Future Med Chem
Sharma S, Kumar S, Gupta J, Mittal A, Khurana N.   +4 more
europepmc   +1 more source

Promising Norlabdane-Heterocyclic Hybrids: Synthesis, Structural Characterization and Antimicrobial Activity Evaluation. [PDF]

Pharmaceuticals (Basel)
Lungu L, Ciocarlan A, Mangalagiu II, Aricu A.   +3 more
europepmc   +1 more source

Synthesis, Anticancer Evaluation, and Molecular Docking of Novel Thiazolobenzimidazole-Thiazole Hybrids as Potent Colon Cancer Inhibitors. [PDF]

ChemistryOpen
Huwaimel B, Abouzied AS, Zaki MEA, Alamri A, Farag B, Alqarni S, Gomha SM.   +6 more
europepmc   +1 more source